Dipartimento di Biotecnologie Molecolari e Scienze per la Salute

Prodotti della ricerca selezionati

1. G. Ermondi, M. Vallaro, G. Caron (2018), Learning how to use IAM chromatography for predicting permeability. Eur. J. Pharm. Sci, vol. 14, pp. 385-390.
2. G. Caron, M. Vallaro, G. Ermondi (2017), The need of implementing Intramolecular Hydrogen Bonding (IMHB) considerations in drug discovery. Measuring the propensity of compounds to form IMHBs. Med. Chem. Comm, vol. 8, pp.1143-1151.
3. G. Caron and G. Ermondi (2017), Why we need to implement intramolecular hydrogen bonding considerations in drug discovery. Fut. Med. Chem. vol. 9, pp. 1-5.
4. G. Caron and G. Ermondi (2017), Updating molecular properties in early drug discovery. DDT, vol 22, pp. 835-840
5. G. Goetz, M. Shalaeva, G. Caron, G. Ermondi, L. Philippe (2017), Relating passive permeability to molecular polarity using Block Relevance analysis. Mol. Pharmaceut. vol. 14, pp. 386-393.
6. G. Caron and G. Ermondi (2016), Molecular descriptors for polarity: the need of going beyond PSA. Fut. Med. Chem. vol. 8, pp 2013-2016.
7. G. Ermondi, G.Caron (2016), Do surface-based match solution-based techniques? The case of drug-liposome interaction, Int. J. Pharm. vol. 508(1-2), pp. 123-127. doi: 10.1016/j.ijpharm.2016.05.018
8. G. Caron, M. Vallaro, G. Ermondi, G. H. Goetz, Y. A. Abramov, L. Philippe, M. Shalaeva (2016), A Fast Chromatographic Method for Estimating Lipophilicity and Ionization in Nonpolar Membrane-Like Environment, Mol. Pharmaceut. vol.13 (3), pp. 1100-1110.
9. G. Ermondi, F. Catalano, M. Vallaro, I. Ermondi, M.P. Camacho Leal, L. Rinaldi, S. Visentin, G. Caron (2015), Lipophilicity of amyloid ß-peptide 12-28 and 25-35 to unravel their ability to promote hydrophobic and electrostatic interactions, Int. J. Pharm. vol 495(1), pp. 179-85.
10. 10. G. Caron, S. Visentin, C. Pontremoli, G. Ermondi (2015), Profile of the intermolecular forces governing the interaction of drugs with mucin, Int. J. Pharm. vol. 488, pp. 67-69.

 

Insegnamenti

• ADVANCED DRUG DISCOVERY (BIO0161 Pds 308-BIDD)
  Master Program in Molecular Biotechnology
• Basic methods in drug discovery (Sezione 1) (BIO0174A)
  Corso di Laurea in Biotecnologie
• COMPUTATIONAL DRUG DISCOVERY (BIO0220)
  Biotechnological and Chemical Sciences in Diagnostics
• COMPUTATIONAL DRUG DISCOVERY (BIO0220)
  Corso di Laurea in Biotecnologie
• COMPUTATIONAL DRUG DISCOVERY (BIO0220 Pds GEN)
  Master Program in Molecular Biotechnology
• Chimica Farmaceutica (Sostanze Dopanti e d’Abuso) (CHI0074)
  Corso di laurea magistrale in Chimica Clinica Forense e dello Sport
• INTEGRATED LABORATORY TECNIQUES (BIO0174)
  Corso di Laurea in Biotecnologie

Temi di ricerca

Gruppi di ricerca

Medicinal Chemistry

Attività in agenda

Consulta la mia agenda

Organi

• Consiglio di Dipartimento

• Commissione monitoraggio e riesame

• Erasmus Committee

• Commissione Monitoraggio e Riesame
• Consiglio del Corso di Studio

Ricevimento studenti

In principle from Monday to Friday from 9 to 12.
Skype calls are encouraged

Linkedin: 

https://www.linkedin.com/in/giulia-caron-73a5275/

Home

Open in Drive